In this video, Dr. Donovan reviews the 20 most influential hair research studies published in the year 2024. This public webinar was conducted on December 30, 2024. The "Top 20" is an annual event that is conducted every year in the month of December.
GROUP 1 STUDIES: MINOXIDIL
Penha MA et al (starts at 1:33). Oral Minoxidil vs Topical Minoxidil for Male Androgenetic Alopecia: A Randomized Clinical Trial. JAMA Dermatol . 2024 Apr 10:e240284.
Salas J et al (starts at 16:25). Characterizing low-dose oral minoxidil-induced peripheral edema in alopecia patients. J Am Acad Dermatol . 2024 Nov 16:S0190-9622(24)03211-0.
Jimenez-Cauhe J et al (starts at 25:13). Safety of Low-Dose Oral Minoxidil in Patients With Hypertension and Arrhythmia: A Multicenter Study of 264 Patients. Actas Dermosifiliogr. 2024 Jan;115(1):28-35.
GROUP 2 STUDIES: FINASTERIDE
O M Moreno-Arrones et al (starts at 39:02). Impact of Finasteride and Dutasteride in Beard Thickness in Men With Androgenetic Alopecia: A 453-patient Retrospective Trial. Actas Dermosifiliogr . 2024 Nov-Dec;115(10):1015-1016.
Chen L-C et al (starts at 44:58). 5α-reductase inhibitor exposure for dermatologic conditions does not increase the risk of female breast or gynecologic cancers: A population-based propensity score-matched cohort study. J Am Acad Dermatol . 2024 Oct 21:
Rohan TZ et al. (starts at 51:29). Risk of estrogen-driven malignancies in females on 5-alpha reductase inhibitors. Arch Dermatol Res . 2024 Nov 26;317(1):46.
GROUP 3 STUDIES: TELOGEN EFFLUVIUM
Godfrey H et al (starts at 55:30). Alopecia associated with the use of semaglutide and tirzepatide: A disproportionality analysis using the FDA adverse event reporting system (FAERS) from 2022 to 2023. J Eur Acad Dermatol Venereol . 2024 Jun 24.
Hirose A et al (starts at 1:03:10). Postpartum hair loss is associated with anxiety. J Obstet Gynaecol Res . 2024 Dec;50(12):2239-2245.
GROUP 4 STUDIES: ALOPECIA AREATA
David E et al (starts at 1:11:59). Dupilumab induces hair regrowth in pediatric alopecia areata: a real-world, single-center observational study. Arch Dermatol Res . 2024 Jul 23;316(7):487. doi: 10.1007/s00403-024-03225-4.
Piliang M et al (starts at 1:21:52). Efficacy and safety of the oral JAK3/TEC family kinase inhibitor ritlecitinib over 24 months: integrated analysis of the ALLEGRO phase 2b/3 and long-term phase 3 clinical studies in alopecia areata. Br J Dermatol . 2024 Oct 21:
Nohria A et al (starts at 1:38:33). Alopecia areata and cardiovascular comorbidities: A cross-sectional analysis of the All of Us research program. JAAD Int. 2024 Apr 8:16:46-48. doi: 10.1016/j.jdin.2024.03.024. eCollection 2024 Sep.
Caldas S et al (starts at 1:43:51). Association of alopecia areata and ischemic heart disease and cerebrovascular in U.S. adults: an all of us database study. Arch Dermatol Res . 2024 May 22;316(5):202. doi: 10.1007/s00403-024-02959-5.
GROUP 5 STUDIES: FRONTAL FIBROSING ALOPECIA
Pindado-Ortega C et al (starts at 1:50:01). Low-dose oral minoxidil for frontal fibrosing alopecia: a 122-patient case series. Actas Dermosifiliogr . 2024 Nov 12:
Chen L-C et al (starts at 1:56:46). Topical tofacitinib for patients with lichen planopilaris and/or frontal fibrosing alopecia. J Am Acad Dermatol. 2024 Jun;90(6):1260-1262.
Williams KN et al (starts at 2:06:32). Topical ruxolitinib in the management of frontal fibrosing alopecia and/or lichen planopilaris: A single-center retrospective cohort study. J Am Acad Dermatol. 2025 Jan;92(1):170-172.
GROUP 6 STUDIES: CENTRAL CENTRIFUGAL CICATRICIAL ALOPECIA
Obi A et al (starts at 2:13:39). Doxycycline for central centrifugal cicatricial alopecia: A single center retrospective analysis. J Am Acad Dermatol . 2024 Aug;91(2):331-333.
Bao A et al (starts at 2:19:16). Low-Dose Metformin and Profibrotic Signature in Central Centrifugal Cicatricial Alopecia. JAMA Dermatol . 2024 Sep 4:e243062. doi: 10.1001/jamadermatol.2024.3062. Online ahead of print.
GROUP 7 STUDIES: FOLLICULITIS DECALVANS
Doche I et al. (starts at 2:24:43). Hydroxychloroquine may be beneficial as an adjuvant therapy for folliculitis decalvans: a 5-year retrospective study with 49 patients. Clin Exp Dermatol. 2024 Sep 28:llae394. doi: 10.1093/ced/llae394.
GROUP 8 STUDIES: SCARRING ALOPECIA (GENERAL)
Kim SR et al (starts at 2:31:57). Association of Primary Cicatricial Alopecia with Subsequent Cardiovascular Disease. J Invest Dermatol. 2024
GROUP 9 STUDIES: LICHEN PLANOPILARIS
Kai-Wen Chuang et al (starts at 2:35:09). Association of lichen planopilaris with cardiovascular and metabolic disorders: A systematic review and meta-analysis. Clin Exp Dermatol . 2024 Oct 18:llae446. doi: 10.1093/ced/llae446. Online ahead of print.
